Myeloma Risk Scores Toolkit

ISS, R-ISS, R2-ISS, mSMART cytogenetic risk, IMWG Frailty, SMM 20/2/20, and HCT-CI

International Staging System (ISS)

Inputs at diagnosis. Units: β2-microglobulin mg/L, albumin g/dL.

Criteria
Stage I: β2M < 3.5 and albumin ≥ 3.5. Stage III: β2M ≥ 5.5. Stage II: all others.